How Wegovy Makes You Feel: A Realistic Guide to Life on Semaglutide

The first two weeks: your stomach is doing most of the talking

Picture this: day four of your first pen, and you've left half a plate of food you'd normally finish without thinking. That's usually the first signal that something has changed. The appetite reduction on Wegovy can arrive faster than many people expect. What tends to follow it, though, is nausea, often described as a low-level queasiness rather than acute sickness, though for some people in the first week it's enough to put them off food entirely.

Loose stools, bloating and a general sense of digestive sluggishness are all common in this opening phase. Fatigue turns up for some people too. None of this means the medicine isn't working properly; it reflects the fact that semaglutide slows gastric emptying quite significantly, and your gut takes time to adapt. Small meals, plain foods and staying well hydrated all help. Most of these early effects settle within ten to fourteen days for people who stick with the starting dose. If they don't ease (or if they're severe from the outset) that's a conversation to have with your prescriber, not something to push through alone. You can read more about how the full experience evolves on our page covering what it's like to be on Wegovy day to day.

As the dose increases: the appetite shift deepens (and so can the side effects)

Wegovy's titration schedule moves through 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg, with roughly four weeks at each level. Each step up can bring a repeat of the first-week queasiness, milder for most people the second or third time around, sharper for others. The appetite suppression, though, tends to deepen in a way that feels qualitatively different by the time you reach the higher doses.

People often describe not just eating less but genuinely not thinking about food the way they used to. The persistent background hunger that many people with obesity experience (the kind that's present even after a full meal) can quieten substantially. That's the effect of semaglutide acting on GLP-1 receptors in the brain's appetite-regulating centres, not just in the gut. A common misconception is that the medicine simply makes food taste different or unpleasant; for most people it's subtler than that, food is just less urgent. Some people do notice altered taste preferences, particularly a reduced pull towards very sweet or fatty foods, but this varies considerably from person to person. Our page on Wegovy and fullness explains the mechanism behind that satiety shift in more detail.

Fatigue can persist for some people across several dose steps. Energy usually stabilises once the GI effects are well managed, which is partly a function of eating enough, since inadequate intake on a strong appetite suppressant is itself a cause of tiredness. Protein and hydration matter more here, not less.

Physical sensations worth knowing about: cold, weakness and other less-discussed effects

Beyond the GI effects, a handful of other physical changes come up regularly. Feeling colder than usual is one of them, a side effect that surprises people because it's not prominently listed on the pack, yet it's a fairly logical consequence of eating less and losing weight, both of which affect how the body generates and conserves heat. If you've noticed this, our page on feeling cold on Wegovy covers what's behind it. Muscle weakness and a feeling of general physical fragility can also develop, particularly when weight loss is happening quickly and protein intake hasn't kept pace. That's worth flagging to your prescriber rather than assuming it's simply how the medicine works. The Wegovy and weakness page goes into when this is expected and when it warrants more attention.

Headaches appear in some people, particularly early on. Dizziness is less common but possible. Injection-site reactions (redness, a small lump, mild soreness) are generally minor and temporary. The NHS semaglutide medicines page lists the full side-effect profile with guidance on which effects to report promptly. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is where you can report any suspected adverse effects, including ones that don't appear on the patient information leaflet.

Longer term: what stabilises and what changes for good

By the time most people reach their maintenance dose and have been on Wegovy for several months, the acute GI effects have usually settled considerably. What tends to remain is the core effect: a quieter relationship with hunger. Meals are smaller. The pull towards high-calorie foods is less intense. Some people describe a genuine sense of ease around food that they hadn't experienced before. Others find the medicine works well on appetite but notice they need to be deliberate about keeping their diet nutritionally balanced, appetite suppression doesn't distinguish between crisps and chicken.

Mood is worth a brief mention. Some people report feeling more in control and less preoccupied with weight, which has a positive effect on how they feel overall. A smaller number notice low mood or changes in how they feel emotionally, particularly if significant side effects are disrupting daily life. These changes should be discussed with a prescriber. If weight management treatment is something you're considering, our consultation page lets you speak to a GPhC-registered prescriber who can assess whether Wegovy or another licensed treatment is the right fit for you. It's worth reading about Wegovy's full licensed profile in the UK first, and if cost is on your mind, the Wegovy price comparison page sets out what private treatment currently involves.